RT Patent
T1 Use of CB2 receptor agonists for promoting neurogenesis
A1 Galve Roperh, Ismael
A1 Guzmán Pastor, Manuel
A1 Mechoulam, Raphael
A1 Palazuelos Diego, Javier
A1 Aguado Sánchez, Tania
AB The present invention relates to ligands of the peripheral cannabinoid receptor CB2, especially (+)-α-pinene derivatives, and to pharmaceutical compositions thereof, which are useful for promoting, inducing and enhancing neurogenesis including neural cell regeneration. In particular, pharmaceutical compositions of the invention will be useful for preventing, alleviating or treating neurological injuries or damages to the CNS or the PNS associated with physical injury, ischemia, neurodegenerative disorders, certain medical procedures or medications, tumors, infections, metabolic or nutritional disorders, cognition or mood disorders, and various medical conditions associated with neural damage or destruction.
YR 2007
FD 2007
LK https://hdl.handle.net/20.500.14352/91719
UL https://hdl.handle.net/20.500.14352/91719
LA eng
NO Cesionario: YISSUMRESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, Jerusalem (IL)
DS Docta Complutense
RD 7 abr 2025